Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price objective lifted by Stifel Nicolaus from $102.00 to $145.00 in a research report released on Wednesday morning, The Fly reports. Several other research analysts have also recently commented on KRYS. William Blair restated an outperform rating on shares of Krystal Biotech in a research report on […]
Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) – Equities research analysts at HC Wainwright raised their Q3 2023 earnings per share (EPS) estimates for Krystal Biotech in a research note issued to investors on Monday, May 22nd. HC Wainwright analyst J. Pantginis now expects that the company will post earnings of ($1.02) per share for […]
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its price target raised by equities research analysts at Stifel Nicolaus from $102.00 to $145.00 in a report issued on Wednesday, The Fly reports. Stifel Nicolaus’ price objective suggests a potential upside of 23.52% from the stock’s current price. Other equities analysts have also recently issued reports about […]
Krystal Biotech (NASDAQ:KRYS – Get Rating) had its target price upped by Chardan Capital from $133.00 to $148.00 in a research note issued to investors on Monday morning, The Fly reports. Other equities analysts have also recently issued research reports about the stock. William Blair reaffirmed an outperform rating on shares of Krystal Biotech in […]